Page 3 - Nasdaq Rvmd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq rvmd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Rvmd Today - Breaking & Trending Today

Revolution Medicines to Report Financial Results for Fourth

REDWOOD CITY, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel. ....

Revolution Medicines Inc , Revolution Medicine , Nasdaq Rvmd , Revolution Medicines ,

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven research firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average […] ....

Hong Kong , United States , Jeff Cislini , Stephen Michael Kelsey , Jpmorgan Chase Co , Hong Kong Ltd , Shell Asset Management Co , Revolution Medicines Inc , Securities Exchange Commission , Us Bancorp , Revolution Medicines Company Profile , Revolution Medicines , Get Free Report , General Counsel Jeff Cislini , Exchange Commission , Kong Ltd , Asset Management , Get Free , Revolution Medicines Daily , Nasdaq Rvmd ,

Revolution Medicines (NASDAQ:RVMD) Stock Price Up 2.7%

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) shares rose 2.7% on Monday . The company traded as high as $29.57 and last traded at $29.22. Approximately 295,122 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 990,351 shares. The stock had previously closed at $28.46. Analyst Upgrades […] ....

Hong Kong , Stephen Michael Kelsey , Jeff Cislini , Revolution Medicines Inc , Hong Kong Ltd , China Universal Asset Management Co , Tower Research Capital , Us Bancorp , Jpmorgan Chase Co , Needham Company , Securities Exchange Commission , Revolution Medicines , Get Free Report , Exchange Commission , General Counsel Jeff Cislini , Kong Ltd , Research Capital , China Universal Asset Management , Universal Asset Management , Revolution Medicines Daily , Nasdaq Rvmd ,

Revolution Medicines, Inc. (NASDAQ:RVMD) General Counsel Jeff Cislini Sells 1,500 Shares

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) General Counsel Jeff Cislini sold 1,500 shares of Revolution Medicines stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $27.00, for a total value of $40,500.00. Following the sale, the general counsel now owns 36,126 shares in the company, […] ....

United States , Jeff Cislini , Group Plc , Revolution Medicines Inc , Voya Investment Management , Jpmorgan Chase Co , Us Bancorp , Revolution Medicines , Get Free Report , General Counsel Jeff Cislini , Investment Management , General Group Plc , Wisconsin Investment Board , Amalgamated Bank , Revolution Medicines Daily , Nasdaq Rvmd , Insider Trading , Nsider Trades ,

Revolution Medicines (NASDAQ:RVMD) Research Coverage Started at Wedbush

Analysts at Wedbush started coverage on shares of Revolution Medicines (NASDAQ:RVMD – Get Free Report) in a research note issued to investors on Thursday, Briefing.com reports. The firm set an “outperform” rating and a $41.00 price target on the stock. Wedbush’s price target suggests a potential upside of 46.48% from the company’s current price. Several […] ....

Stifel Nicolaus , Raymond James , Marka Goldsmith , Stephen Michael Kelsey , Jpmorgan Chase Co , Revolution Medicines Inc , Pricet Rowe Associates Inc , Farallon Capital Management , Vanguard Group Inc , Securities Exchange Commission , Revolution Medicines Company Profile , Revolution Medicines , Get Free Report , Medicines Stock Down , Exchange Commission , Capital Management , Pricet Rowe Associates , Revolution Medicines Daily , Nasdaq Rvmd , Initiated Coverage ,